Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau.
Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses were determined in cultures of peripheral blood mononuclear cells from HIV-2-exposed uninfected individuals, HIV-2-infected individuals and HIV-negative controls in Guinea-Bissau. Increased HIV-2-specific T lymphocyte proliferative responses were detected in both groups compared to HIV-negative controls (healthy HIV-uninfected individuals without known exposure to an HIV-infected person); five out of 29 of the HIV-2-exposed uninfected and half (16 of 32) of the HIV-2-infected individuals had stimulation indexes >2, compared to one out of 49 of the HIV-negative controls (P = 0.003 and P < 0.0001, respectively). The exposed uninfected individuals had reactivity to a HIV-2 V3-peptide corresponding to amino acids 311-326 of the envelope glycoprotein, while the HIV-2-infected people reacted mainly to HIV-2 whole viral lysate. Thus, this study demonstrates a high degree of HIV-2-specific T helper cell activity, as measured by lymphocyte proliferation, in HIV-2-exposed uninfected individuals as well as in HIV-2-infected subjects. These immune responses could be important for resistance to the infection and for the control of established infection and, thus, play a role in the lower transmission and progression of HIV-2 compared to HIV-1.
Andersson
S
S
Swedish Institute for Infectious Disease Control and the Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden. soren.andersson@orebroll.se
Larsen
O
O
Da Silva
Z
Z
Linder
H
H
Norrgren
H
H
Dias
F
F
Thorstensson
R
R
Aaby
P
P
Biberfeld
G
G
D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D016022:Case-Control Studies; D018929:Cell Culture Techniques; D049109:Cell Proliferation; D004198:Disease Susceptibility; D005260:Female; D006169:Guinea-Bissau; D015658:HIV Infections / Q000276:immunology*; D015498:HIV-2 / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D008297:Male; D011247:Pregnancy; D011446:Prospective Studies; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000821:virology
D000914:Antibodies, Viral
AIDS. 2000 Mar 10;14(4):441-8
10770548
AIDS Res Hum Retroviruses. 1998 Nov 20;14(17):1521-30
9840285
Vaccine. 2000 Sep 15;19(2-3):298-307
10930685
J Acquir Immune Defic Syndr. 2000 Jul 1;24(3):257-63
10969350
Arch Intern Med. 2000 Nov 27;160(21):3286-93
11088091
J Clin Invest. 2001 Feb;107(3):341-9
11160158
J Clin Invest. 2001 May;107(10):1303-10
11375420
AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1155-65
11522185
Immunol Lett. 2001 Nov 1;79(1-2):3-13
11595284
J Infect Dis. 2002 Apr 1;185(7):905-14
11920314
J Reprod Immunol. 2003 Feb;58(1):79-91
12609527
J Gen Virol. 2003 May;84(Pt 5):1287-99
12692296
J Virol. 2004 Jul;78(13):7016-22
15194778
N Engl J Med. 1983 Jul 7;309(1):13-7
6602294
J Virol. 1987 Jun;61(6):2017-23
3033328
AIDS. 1988 Jun;2(3):195-9
3134913
AIDS Res Hum Retroviruses. 1988 Jun;4(3):175-86
2840105
J Immunol. 1989 Feb 15;142(4):1166-76
2783706
J Clin Invest. 1989 Apr;83(4):1198-203
2703528
J Immunol. 1990 Dec 15;145(12):4348-54
2258623
AIDS. 1991 Jul;5(7):859-63
1892591
J Acquir Immune Defic Syndr. 1992;5(1):25-30
1738085
J Infect Dis. 1992 Jun;165(6):1012-9
1533867
Eur J Immunol. 1992 Sep;22(9):2211-7
1381309
J Acquir Immune Defic Syndr. 1993 Aug;6(8):941-8
8315578
AIDS Res Hum Retroviruses. 1993 May;9(5):431-8
8318269
J Virol. 1993 Aug;67(8):5035-40
8331739
AIDS. 1993 Jul;7(7):989-93
8357558
J Immunol. 1993 Sep 15;151(6):3361-9
7690804
JAMA. 1993 Nov 3;270(17):2083-6
8147962
AIDS. 1993 Oct;7(10):1389-91
8267915
J Immunol. 1994 Feb 15;152(4):1952-9
8120399
J Clin Invest. 1994 Mar;93(3):1293-7
8132769
Lancet. 1994 Apr 16;343(8903):943-6
7909009
Science. 1994 Sep 9;265(5178):1587-90
7915856
Nature. 1995 Jan 12;373(6510):117-22
7529365
Nature. 1995 Jan 12;373(6510):123-6
7816094
AIDS. 1994 Oct;8(10):1391-5
7818809
Virology. 1995 Jan 10;206(1):673-8
7831824
Clin Immunol Immunopathol. 1995 Aug;76(2):135-41
7614732
AIDS. 1995 Jun;9(6):555-9
7662192
J Immunol. 1999 Jan 1;162(1):540-9
9886431
J Virol. 1999 Jan;73(1):436-43
9847349
J Hum Virol. 1998 Nov-Dec;1(7):457-68
10195267
AIDS. 1999 Apr 16;13(6):701-7
10397565
AIDS Res Hum Retroviruses. 1999 Jul 20;15(11):957-62
10445807
J Infect Dis. 1999 Oct;180(4):1116-21
10479138
Nat Med. 1995 Jan;1(1):59-64
7584954
J Med Virol. 1995 Oct;47(2):139-44
8830117
J Infect Dis. 1996 Nov;174(5):977-85
8896498
J Virol. 1997 Jul;71(7):4981-4
9188561
Nat Med. 1997 Nov;3(11):1250-7
9359700
Science. 1997 Nov 21;278(5342):1447-50
9367954
AIDS. 1997 Dec;11(15):1815-22
9412699
J Infect Dis. 1998 Jan;177(1):65-71
9419171
AIDS. 1997;11 Suppl A:S99-107
9451973
J Virol. 1998 Mar;72(3):2439-48
9499105
J Virol Methods. 1998 Feb;70(2):139-51
9562408
AIDS. 1998;12 Suppl A:S133-40
9632994
AIDS Res Hum Retroviruses. 1998 Jun;14 Suppl 2:S143-7
9672231
AIDS. 1998 Sep 10;12(13):1707-14
9764792
J Infect Dis. 2000 May;181(5):1581-9
10823757